CollPlant Biotechnologies (CLGN) Intangibles (2017 - 2026)
CollPlant Biotechnologies (CLGN) reported Intangibles of $59000.0 for Q1 2026, down 99.95% on a YoY basis from $116.0 million in Q1 2025, and down 19.18% quarter-over-quarter from $73000.0 in Q4 2025.
CollPlant Biotechnologies (CLGN) Intangibles (2017 - 2026) Analysis & Trends
CollPlant Biotechnologies has reported Intangibles for 10 years, with the latest figure at $59000.0 in Q1 2026.
- For the quarter ending Q1 2026, Intangibles fell 99.95% year-over-year to $59000.0; the trailing twelve-month figure through Mar 2026 stood at $59000.0 (down 99.95% YoY), and the FY2025 full-year result was $73000.0, down 99.94% from the prior year.
- Intangibles for Q1 2026 stood at $59000.0, down from $73000.0 in the prior quarter.
- The five-year high for Intangibles was $245.0 million in Q4 2022, with the low at $59000.0 in Q1 2026.
- Historically, Intangibles has averaged $63.4 million across 5 years, with a median of $236500.0 in 2022.
- Annual changes were most pronounced in 2023 — Intangibles surged 84773.95% — and 2026, when it sank 99.95%.
- CollPlant Biotechnologies' Intangibles stood at $245.0 million in 2022, then tumbled by 99.92% to $188000.0 in 2023, then surged by 69580.85% to $131.0 million in 2024, then tumbled by 99.94% to $73000.0 in 2025, then decreased by 19.18% to $59000.0 in 2026.
- The last three Intangibles figures came in at $59000.0 (Q1 2026), $73000.0 (Q4 2025), and $102000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | 4.41 Mn |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | 30.30 Mn |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 418.50 Mn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | 7.73 Mn |
| 10 | CollPlant Biotechnologies | 7.20 Mn | 7.20 Mn | - | 59,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 59,000.00 |
| Dec 31, 2025 | 73,000.00 |
| Jun 30, 2025 | 102,000.00 |
| Mar 31, 2025 | 116.00 Mn |
| Dec 31, 2024 | 131.00 Mn |
| Sep 30, 2024 | 145.00 Mn |
| Jun 30, 2024 | 159,000.00 |
| Mar 31, 2024 | 173.00 Mn |
| Dec 31, 2023 | 188,000.00 |
| Sep 30, 2023 | 202.00 Mn |
| Jun 30, 2023 | 216,000.00 |
| Mar 31, 2023 | 231,000.00 |
| Dec 31, 2022 | 245.00 Mn |
| Sep 30, 2022 | 238,000.00 |
| Jun 30, 2022 | 235,000.00 |
| Mar 31, 2022 | 239,000.00 |
| Dec 31, 2021 | 243.00 Bn |
| Sep 30, 2021 | 194,000.00 |
| Jun 30, 2021 | 164,000.00 |
| Mar 31, 2021 | 138.00 Mn |